Wei-Hsuan "Jenny" Lo-Ciganic, Ph.D., M.S., M.S.Pharm.
Associate Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6255
Business Email:
wlociganic@ufl.edu
About Wei-Hsuan "Jenny" Lo-Ciganic
Wei-Hsuan “Jenny” Lo-Ciganic, M.S.Pharm, M.S., Ph.D. is an associate professor in the University of Florida College of Pharmacy, Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety. As a pharmacist and pharmacoepidemiologist and pharmaceutical health services researcher, she applies well-thought-out pharmacoepidemiological approaches to address relevant issues in clinical practice, to make appropriate recommendations to health care professionals, and to enhance drug safety. Her research focuses on improving drug safety, medication adherence, pain management, quality of prescribing, and treatment for substance use disorders, especially among vulnerable populations (e.g., Medicaid beneficiaries). Dr. Lo-Ciganic has extensive experience applying advanced predictive analytics including machine learning and group-based trajectory modeling with large healthcare datasets.
Since her faculty appointment in 2015, Lo-Ciganic served as Principal Investigator (PI) and Co-Investigator (Co-I) on more than 13 extramurally-funded grants and contracts. For example, she was the PI of an R21 grant, entitled “Developing a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older Adults” funded by the National Institute on Aging. She is currently the PI for the R01 study entitled “Developing and Evaluating a Machine-Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE)” funded by NIDA. Recently, she became a Site PI for the R01 grant, entitled “Machine-Learning Prediction and Reducing Overdoses with EHR Nudges (mPROVEN)” funded by NIDA. She has published more than 75 peer-reviewed manuscripts with an h-index of 21. Since 2015, she has been a member and co-chair of the Pharmacy Quality Alliance’s (PQA) workgroups and Quality Metrics Expert Panel to develop and improve quality measures of prescription medications.
Accomplishments
2022 University of Florida College of Pharmacy Research Impact Award
2022
·
University of Florida College of Pharmacy
2020 Outstanding Reviewer
2021
·
Annals of Internal Medicine
2021 Young Outstanding Alumni Award
2021
·
National Cheng-Kung University, Taiwan
2020 University of Florida College of Pharmacy Outstanding Clinical Science Publication Award
2020
·
University of Florida
2020 University of Florida Excellence Awards for Assistant Professor
2020
·
University of Florida
2018 Best Reviewer
2019
·
Pharmacoepidemiology and Drug Safety
2018 Outstanding Reviewer
2019
·
Annals of Internal Medicine
2016 Outstanding Reviewer
2017
·
Annals of Internal Medicine
2017 Best Podium Presentation Award
2017
·
2017 International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual Meeting
Grant Mentoring and Career Development Program Awardee
2017
·
U.S. Bone and Joint Initiative/Bone and Joint Canada Young Investigators Initiative (YII)
Teaching Profile
Courses Taught
2020-2021
PHA6268 Pharmacoepidemiology and Patient Safety
2020-2021,2023
PHA7980 Research for Doctoral Dissertation
2020-2023
PHA6910 Supervised Research
2020-2023
PHA7979 Advanced Research
2019-2023
PHA5244 Prin Evid Based Prac
2020-2021
PHA6971 Research for Master’s Thesis
2020-2023
PHA6935 Selected Topics in Pharmacy
2021
PHA6937 Topics in Pharmaceutical Administration
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2021-2023
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6940 Supervised Teaching
2021
PHA5930 Sem Pharm Research
2022
PHA5933 Select Top Pharmacy
2022-2023
PHA6946 Practicum in the Pharmaceutical Sciences
2023
PHA5243 Principles of Pharmacy Informatics
2023
PHA6241 Introduction to Artificial Intelligence in Pharmacy
Research Profile
Pharmacoepidemiology, pharmaceutical health service research, patient safety, quality of prescribing and care, program and policy evaluation, medication adherence, prescription drug abuse and substance use disorders and advanced analytics including trajectory analysis, machine learning and spatial pattern mining
Open Researcher and Contributor ID (ORCID)
0000-0001-6590-4770
Publications
2023
Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
Journal of Clinical Medicine.
12(5)
[DOI] 10.3390/jcm12051788.
[PMID] 36902574.
2023
Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C.
Medical care.
61(2):81-86
[DOI] 10.1097/MLR.0000000000001801.
[PMID] 36453625.
2023
Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs
American Journal of Preventive Medicine.
64(1):96-104
[DOI] 10.1016/j.amepre.2022.08.016.
[PMID] 36257884.
2023
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012–2021
Journal of Clinical Medicine.
12(19)
[DOI] 10.3390/jcm12196286.
2022
Association of low-income subsidy, medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries.
Research in social & administrative pharmacy : RSAP.
18(4):2634-2642
[DOI] 10.1016/j.sapharm.2021.05.005.
[PMID] 34006485.
2022
Changes in predicted opioid overdose risk over time in a state Medicaid program: a group‐based trajectory modeling analysis
Addiction.
117(8):2254-2263
[DOI] 10.1111/add.15878.
[PMID] 35315173.
2022
Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review.
European journal of clinical pharmacology.
78(8):1217-1225
[DOI] 10.1007/s00228-022-03346-7.
[PMID] 35657416.
2022
Comparison of effectiveness and safety for low versus full dose of apixaban during extended phase oral anticoagulation in patients with venous thromboembolism.
Journal of internal medicine.
291(6):877-885
[DOI] 10.1111/joim.13462.
[PMID] 35192737.
2022
Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study
PLOS Medicine.
19(3)
[DOI] 10.1371/journal.pmed.1003921.
[PMID] 35231025.
2022
Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study.
The Lancet. Digital health.
4(6):e455-e465
[DOI] 10.1016/S2589-7500(22)00062-0.
[PMID] 35623798.
2022
Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group‐based multi‐trajectory models
Addiction.
117(7):1982-1997
[DOI] 10.1111/add.15857.
2022
Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003–2018
Journal of Clinical Medicine.
11(13)
[DOI] 10.3390/jcm11133671.
[PMID] 35806956.
2022
Machine Learning Algorithms for Predicting Direct-Acting Antiviral Treatment Failure in Chronic Hepatitis C: An HCV-TARGET Analysis
Hepatology.
76(2):483-491
[DOI] 10.1002/hep.32347.
[PMID] 35034373.
2022
Predictive Modeling for Suicide-Related Outcomes and Risk Factors among Patients with Pain Conditions: A Systematic Review
Journal of Clinical Medicine.
11(16)
[DOI] 10.3390/jcm11164813.
[PMID] 36013053.
2022
Readmission Prediction for Patients with Heterogeneous Medical History: A Trajectory-Based Deep Learning Approach
ACM Transactions on Management Information Systems.
13(2):1-27
[DOI] 10.1145/3468780.
2022
Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data
Journal of Clinical Medicine.
11(5)
[DOI] 10.3390/jcm11051401.
[PMID] 35268492.
2022
Using Data Science to Improve Outcomes for Persons with Opioid Use Disorder
Substance Abuse.
43(1):956-963
[DOI] 10.1080/08897077.2022.2060446.
[PMID] 35420927.
2021
Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
24(2):196-205
[DOI] 10.1016/j.jval.2020.12.001.
[PMID] 33518026.
2021
Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida’s Acute Pain Opioid Restriction Law.
Journal of managed care & specialty pharmacy.
27(6):779-784
[DOI] 10.18553/jmcp.2021.27.6.779.
[PMID] 34057389.
2021
Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults
American Journal of Preventive Medicine.
62(4):519-528
[DOI] 10.1016/j.amepre.2021.08.024.
[PMID] 34802816.
2021
Dual‐trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study
Addiction.
116(4):819-830
[DOI] 10.1111/add.15189.
[PMID] 32648951.
2021
Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.
Journal of managed care & specialty pharmacy.
27(10):1388-1402
[DOI] 10.18553/jmcp.2021.27.10.1388.
[PMID] 34595949.
2021
Industry Payments to Physicians and Prescribing Branded Memantine and Donepezil Combination.
Neurology. Clinical practice.
11(3):181-187
[DOI] 10.1212/CPJ.0000000000000870.
[PMID] 34484885.
2021
Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach
PLOS ONE.
16(3)
[DOI] 10.1371/journal.pone.0248360.
[PMID] 33735222.
2021
Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.
Journal of general internal medicine.
36(4):908-915
[DOI] 10.1007/s11606-020-06405-w.
[PMID] 33481168.
2021
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders.
Hepatology (Baltimore, Md.).
74(2):566-581
[DOI] 10.1002/hep.31732.
[PMID] 33544904.
2021
Trends in Sexually Transmitted Infections in United States Ambulatory Care Clinics from 2005–2016
Journal of Clinical Medicine.
11(1)
[DOI] 10.3390/jcm11010071.
[PMID] 35011812.
2020
<p>Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder</p>
Neuropsychiatric Disease and Treatment.
Volume 16:1433-1450
[DOI] 10.2147/ndt.s241749.
2020
Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
Neuropsychiatric Disease and Treatment.
Volume 16:1433-1450
[DOI] 10.2147/ndt.s241749.
2020
Aromatase Inhibitors and Risk of Arthritis and Carpal Tunnel Syndrome among Taiwanese Women with Breast Cancer: A Nationwide Claims Data Analysis
Journal of Clinical Medicine.
9(2)
[DOI] 10.3390/jcm9020566.
[PMID] 32092973.
2020
Association between race/ethnicity and the risk of amputation of lower extremities among medicare beneficiaries with diabetic foot ulcers and diabetic foot infections.
BMJ open diabetes research & care.
8(1)
[DOI] 10.1136/bmjdrc-2020-001328.
[PMID] 32843499.
2020
Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism
American Journal of Health-System Pharmacy.
77(3):188-195
[DOI] 10.1093/ajhp/zxz307.
[PMID] 31974557.
2020
Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region.
Journal of managed care & specialty pharmacy.
26(10):1309-1316
[DOI] 10.18553/jmcp.2020.26.10.1309.
[PMID] 32996396.
2020
Health Outcomes Associated with Adherence to Antidepressant Use during Acute and Continuation Phases of Depression Treatment among Older Adults with Dementia and Major Depressive Disorder
Journal of Clinical Medicine.
9(10)
[DOI] 10.3390/jcm9103358.
[PMID] 33092169.
2020
Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients With Advanced Melanoma: A Systematic Review and Network Meta-analysis
JAMA Network Open.
3(3)
[DOI] 10.1001/jamanetworkopen.2020.1611.
[PMID] 32211869.
2020
Listed below are the 20 most recent articles to view the complete list click here
.
2020
Occupational Patterns of Opioid-Related Overdose Deaths Among Arizona Medicaid Enrollees, 2008-2017
Journal of General Internal Medicine.
35(7):2210-2213
[DOI] 10.1007/s11606-020-05684-7.
[PMID] 32043261.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009-2014
Journal of psychosomatic obstetrics and gynecology (Online).
1-7
[DOI] 10.1080/0167482X.2020.1727882.
[PMID] 32067526.
2020
Trajectories of Short Physical Performance Battery Are Strongly Associated with Future Major Mobility Disability: Results from the LIFE Study
Journal of Clinical Medicine.
9(8)
[DOI] 10.3390/jcm9082332.
[PMID] 32707877.
2020
Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study
PLOS ONE.
15(7)
[DOI] 10.1371/journal.pone.0235981.
[PMID] 32678860.
2019
Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States
Pharmacoepidemiology and Drug Safety.
28(1):80-89
[DOI] 10.1002/pds.4647.
[PMID] 30192041.
2019
Alzheimer’s disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study
Alzheimer's & dementia. Translational research & clinical interventions.
5:294-302
[DOI] 10.1016/j.trci.2019.05.005.
[PMID] 31338414.
2019
Alzheimer’s disease medication and risk of all-cause mortality and all-cause hospitalization: a retrospective cohort study.
.
10(5):294-302
2019
Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
Bmc Health Services Research.
19(1)
[DOI] 10.1186/s12913-019-4520-4.
[PMID] 31619229.
2019
Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes
Pain Medicine.
21(9):1871-1890
[DOI] 10.1093/pm/pnz234.
[PMID] 31626295.
2019
Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescription.
JAMA Network Open.
2(3)(e190968)
2019
Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescription.
JAMA Network Open.
2(3)(e190968)
2019
Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions
JAMA Network Open.
2(3)
[DOI] 10.1001/jamanetworkopen.2019.0968.
[PMID] 30901048.
2019
Extent and predictors of potentially inappropriate antidepressant use among older adults with dementia and major depressive disorder
The American Journal Of Geriatric Psychiatry.
27(8):794-805
2019
Lack of Evidence that Beta Blocker Use Reduces Knee Pain, Areas of Joint Pain, or Analgesic Use among Individuals with Symptomatic Knee Osteoarthritis
Osteoarthritis and cartilage.
28(1):53-61
[DOI] 10.1016/j.joca.2019.08.008.
[PMID] 31526877.
2019
Patterns of Opioid Administration Among Opioid-Naive Inpatients and Associations With Postdischarge Opioid Use: A Cohort Study
Annals of Internal Medicine.
171(2):81-90
[DOI] 10.7326/M18-2864.
[PMID] 31207646.
2019
Patterns of opioid administration among opioid-naïve inpatients and associations with postdischarge opioid use: A cohort study.
.
2019
Patterns of opioid administration among opioid-naïve inpatients and associations with postdischarge opioid use: A cohort study.
.
2019
Patterns of opioid administration among opioid-naïve inpatients and associations with postdischarge opioid use: A cohort study.
.
2019
Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016
Journal of Clinical Medicine.
9(1)
[DOI] 10.3390/jcm9010083.
[PMID] 31905718.
2018
Influence of peer networks on physician adoption of new drugs.
PLoS One.
13(10)
2018
Influence of peer networks on physician adoption of new drugs.
PLoS One.
13(10)
2018
Influence of peer networks on physician adoption of new drugs.
PLoS One.
13(10)
2018
Misoprostol in addition to a double balloon catheter for induction: A double-blind randomized controlled trial.
American Journal of Perinatology.
35(3):225-232
2018
Misoprostol in addition to a double balloon catheter for induction: A double-blind randomized controlled trial.
American Journal of Perinatology.
35(3):225-232
2018
Misoprostol in addition to a double balloon catheter for induction: A double-blind randomized controlled trial.
American Journal of Perinatology.
35(3):225-232
2018
Patterns and predictors of physician adoption of new cardiovascular drugs
.
6(1):33-40
2018
Prescription opioid quality measures applied among Pennsylvania Medicaid enrollees.
Journal Of Managed Care & Specialty Pharmacy.
24(9):875-885
2017
An examination of claims-based predictors of overdose from a large Medicaid program.
.
55(3):291-298
2017
Analgesic use and risk of recurrent falls in participants with or at risk of knee osteoarthritis: data from the Osteoarthritis Initiative
Osteoarthritis and Cartilage.
25(9):1390-1398
[DOI] 10.1016/j.joca.2017.03.017.
[PMID] 28385483.
2017
Effectiveness and safety of non-Vitamin K antiagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses.
Clinical Therapeutics.
39(7):1456-1478
2017
Medicaid prior authorization and opioid medication abuse and overdose.
American Journal of Managed Care.
23(5):e164-e171
2017
Medication-assisted treatment and opioid use before and after overdose in Pennsylvania Medicaid.
Jama-Journal of the American Medical Association.
318(8):750-752
2016
Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization
Addiction.
111(5):892-902
[DOI] 10.1111/add.13270.
[PMID] 26662858.
2016
Partnership building and implementation of an integrated healthy-aging program.
Progress in Community Health Partnerships-Research Education and Action.
10(1):123-132
2016
Pilot enhancement of the Arthritis Foundation exercise program with a healthy aging program
Research in Gerontological Nursing.
9(3):123-132
[DOI] 10.3928/19404921-20151019-04.
[PMID] 26501346.
2016
Pilot enhancement of the Arthritis Foundation exercise program with a healthy aging program.
Research in Gerontological Nursing.
9(3):123-132
2016
The preventive services use self-efficacy (PRESS) scale in older women: development and psychometric properties.
Bmc Health Services Research.
16(1)
2016
The preventive services use self-efficacy (PRESS) scale in older women: development and psychometric properties.
Bmc Health Services Research.
16(1)
2016
The preventive services use self-efficacy (PRESS) scale in older women: development and psychometric properties.
Bmc Health Services Research.
16(1)
2016
Trajectories of diabetes medication adherence and hospitalization risk: A retrospective cohort study in a large state Medicaid program
Journal of General Internal Medicine.
31(9):1052-1060
2016
Treatment quality for buprenorphine care: The pot at the end of the rainbow. [In Reply to “Measurement Quality of Buprenorphine Care”].
Journal of Addiction Medicine.
10(3):210-211
2016
Who were the early adopters of dabigatran? An application of group-based trajectory models.
.
54(7):725-732
2015
Defining non-medical use of prescription opioids within health care claims: a systematic review
Substance Abuse.
36(2):192-202
[DOI] 10.1080/08897077.2014.993491.
[PMID] 25671499.
2015
Patterns and quality of buprenorphine opioid agonist treatment in a large Medicaid program
Journal of Addiction Medicine.
9(6):470-477
[DOI] 10.1097/ADM.0000000000000164.
[PMID] 26517324.
2015
Statin Use and Decline in Gait Speed in Community-Dwelling Older Adults
Journal of the American Geriatrics Society.
63(1):124-129
[DOI] 10.1111/jgs.13134.
[PMID] 25537649.
2015
Use of common analgesics is not associated with ovarian cancer survival
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
24(8):1291-1294
[DOI] 10.1158/1055-9965.EPI-15-0508.
[PMID] 26063476.
2015
Using machine learning to examine medication adherence thresholds and risk of hospitalization
Medical care.
53(8):720-728
[DOI] 10.1097/MLR.0000000000000394.
[PMID] 26147866.
2014
Aspirin, non-aspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium
Journal of the National Cancer Institute.
106(2)
[DOI] 10.1093/jnci/djt431.
[PMID] 24503200.
2013
Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults
The Annals of pharmacotherapy.
47(7-8):984-992
[DOI] 10.1345/aph.1S050.
[PMID] 23780807.
2013
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls
Cancer Prevention Research.
6(8):811-821
[DOI] 10.1158/1940-6027.CAPR-13-0037.
[PMID] 23761272.
2012
Aspirin, non-aspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer
Epidemiology.
23(2):311-319
[DOI] 10.1097/EDE.0b013e3182456ad3.
[PMID] 22252409.
2011
Identifying type 1 and type 2 diabetic cases using administrative data: a tree-structured model
Journal Of Diabetes Science And Technology.
5(3):486-493
[DOI] 10.1177/193229681100500303.
[PMID] 21722564.
2004
Antihypertensive agents and new-onset diabetes
.
16:225-240
2004
Selective serotonin reuptake inhibitors (SSRI)
.
14(6)
Grants
Sep 2023
ACTIVE
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool
Role: Co-Investigator
Funding: NATL INST OF HLTH NIDA
Jun 2023
ACTIVE
Longitudinal impact of narcolepsy and cardiovascular disease: A claims-based study
Role: Co-Investigator
Funding: SLEEP RESEARCH SOCIETY FOUNDATION
Jan 2023
ACTIVE
Real-World Trajectories of Xanthine Oxidase Inhibitor Use and Downstream Cardiovascular Outcomes
Role: Other
Funding: AMER HEART ASSOCIATION
Jul 2022
ACTIVE
Machine-Learning Prediction and Reducing Overdoses with EHR Nudges (mPROVEN)
Role: Principal Investigator
Funding: UNIV OF PITTSBURGH
via NATL INST OF HLTH NIDA
Jul 2021
ACTIVE
Developing and Evaluating a Machine-Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE)
Role: Principal Investigator
Funding: NATL INST OF HLTH NIDA
Jul 2021
– Dec 2022
Predicting Risky Opioid Therapy e-Care Tool (PROTeCT): Prototype Development and Pilot Testing
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL
May 2021
– Dec 2022
Utilization patterns of cough medications in the United States
Role: Principal Investigator
Funding: MERCK AND COMPANY INC
Mar 2021
– May 2022
VA IPA – Nursing Unit Design and Hospital Falls 2021-2022
Role: Principal Investigator
Funding: US DEPT OF VET AFF GAINESVILLE MED CTR
Sep 2020
ACTIVE
Linking VA and non-VA data to study the risk of suicide in chronic pain patients
Role: Co-Investigator
Funding: WEILL MED COLLEGE OF CORNELL UNIV
via NATL INST OF HLTH NIMH
Jul 2020
ACTIVE
Implementing Opioid Risk Prediction Models
Role: Principal Investigator
Funding: UNIV OF PITTSBURGH
via RICHARD KING MELLON FOU
Jan 2020
– Feb 2021
Leveraging social media data for evaluation of drug use trends after opioid policies
Role: Co-Investigator
Funding: AMER ASSO OF COL OF PHARMACY
May 2019
– Jan 2022
Developing a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older Adults
Role: Principal Investigator
Funding: NATL INST OF HLTH NIA
Jul 2018
– Jun 2022
Using Machine Learning to Predict Problematic Opioid Use and Opioid Overdoses
Role: Principal Investigator
Funding: UNIV OF PITTSBURGH
via NATL INST OF HLTH NIDA
Jul 2018
– Jun 2020
Machine Learning and Opioid Overdoses
Role: Principal Investigator
Funding: UNIV OF PITTSBURGH
via RICHARD KING MELLON FOU
Education
Ph.D.
2013
·
University of Pittsburgh
M.S.
2010
·
University of Pittsburgh
M.S.Pharm.
2005
·
National Cheng Kung University
B.S.
2003
·
National Taiwan University
Contact Details
Phones:
- Business:
- (352) 273-6255
Emails:
- Business:
- wlociganic@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
HPNP 3338
GAINESVILLE FL 326103007
Recent news
New AI tool will predict patients at high risk for opioid use disorder and overdose
UF researchers will use data from patients’ electronic medical records to help clinicians safely and effectively prescribe opioid medications.
Machine-learning algorithm led by UF researcher improves the prediction of opioid overdose by integrating health claims data with public human services data
The study led by Dr. Weihsuan “Jenny” Lo-Ciganic was published by PLOS One.
Drs. Lo-Ciganic and Hincapie-Castillo appointed as section co-editors for Pain Medicine journal
Pain Medicine is a multidisciplinary journal dedicated to pain clinicians, educators and researchers with an interest in pain from various medical specialties.
Dr. Weihsuan “Jenny” Lo-Ciganic to lead virtual ISPOR workshop on machine learning
Weihsuan “Jenny” Lo-Ciganic, Ph.D., M.S., M.S.Pharm., will lead a short course workshop on machine learning as part of the International Society for Pharmacoeconomics and Outcomes Research’s Virtual ISPOR 2020 Conference from 10 a.m.…